Amrutanjan Health Care Share Price

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennaibased Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on inhouse research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages hygiene and services in pain management.Amrutanjan has an agreement with a company in Philadelphia, US, to supply custommade chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 199697, it has introduced a new product called Cold Snap Gel and also a mint called tingle. Company having two subsidiary companies viz. Amrutanjan Drugs Chemicals Ltd having holding stake 99.80% Amrutanjan Finance Ltd, having holding stake is 57.26%.Company has taken efforts to increase the export of fine chemicals also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover net Profit of the Company.Diakyur for the treatment of Diabetes was introduced during 20002001. The name of Company changed from Amrutanjan Limited to Amrutanjan Health Care Limited during the year 200708. During the year 200910, the name of the Fine Chemicals Division of the Company was changed to Pharmaessense Chemistry Services Division.During April 2011 a new division under the name Amrutanjan Pain Management Center also known as CARE Specialized Pain Management Center was launched in Chennai. The Pharmaessense Chemistry Services Division was transferred to a wholly owned Subsidiary Company viz., Amrutanjan Pharmaessense Private Limited with all its assets and liabilities, excluding land during May 2011. Sivas Soft Drink Private Limited was acquired during February 2011 by way of transfer of shares. The Company launched Amrutanjan Headache Faster Relaxation Rollon 10ml SKU launched Amrutanjan Faster Relaxation Balm(white) during the year 201415.In FY 201617, the Subsidiary Company, Amrutanjan Pharmaessense Private Limited (Transferor Company) got merged with the Holding Company (M/s. Amrutanjan Health Care Limited/ Transferee Company), through Scheme of Amalgamation, effective from 1st July 2016. Accordingly, the assets and liabilities of Amrutanjan Pharmaessense Pvt Ltd as at 01st July, 2016 was taken over by the Company.Amrutanjan Comfy Snug Fit Sanitary napkin was launched in 201617. Comfy Snug Fit was launched in 2016. The New Maha Strong Pain Balm was relaunched in 2016. Orange variant was launched in addition to existing Apple variant during financial year 201819. The flavour Alphonso, the King of Mangoes, was launched in 200 ml Ready to drink recyclable PET format. Two more new variants, Comfy XLand Comfy Ultra were launched during 201920. The Company relaunched its headache Pain balm in 202122. It introduced Amrutanjan Comfy Sung Fit Regular Cottony in FY22. A new product, Amrutanjan Stop Pain Dental Gel was launched for Oral Health Care in 2023. In FY 2024, it launched Pain cream and Electro Plus Lemon and Lowsugar variants.In FY 2025, Company launched Amrutanjan Faster Relaxation Rollon (AFRR) 2.5ml for pain relief. To address hydration and wellness, Electro+ expanded with two scientifically backed solutions: Electro+ Tetra and Electro+ Powder, both formulated with the WHOrecommended formula to address dehydration from conditions such as diarrhoea and vomiting. To increase affordability and reach, Company launched Electro+ Rehydrate 160ml. Recognising the widespread reliance on oral medication for menstrual pain often with side effects, Amrutanjan launched the Comfy Period Pain Relief RollOn: Ayurvedic, sideeffectfree, topical solution. A key milestone was the rapid expansion of the Quick Commerce (QCOM) channel, enabling delivery within minutes and reinforcing the brands promise of relief in 10 minutes.

As of Sep '25, Amrutanjan Health Care’s market capitalisation stood at ₹1,932.10 crores. Shareholding as of Sep '25 shows promoters holding 46.5%, with FIIs at 2.4%, DIIs at 12.9%, and public at 38.2%.

As of 4 Dec 2025, Amrutanjan Health Care share price is ₹668.3. The stock opened at ₹677.2 and had closed at ₹672.7 the previous day. During today’s trading session, Amrutanjan Health Care share price moved between ₹666.00 and ₹677.20, with an average price for the day of ₹671.60. Over the last 52 weeks, the stock has recorded a low of ₹544.10 and a high of ₹842.90. In terms of performance, Amrutanjan Health Care share price has declined by 8.3% over the past six months and has declined by 15.42% over the last year.